ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Synthetic Biologics Inc

Synthetic Biologics Inc (SYN)

1,02
0,00
(0,00%)
Fermé 18 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,02
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
1,02
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
17 043 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,58
Bénéfice par action (BPA)
-1,08
Chiffre d'affairess
-
Bénéfice net
-18,35M

À propos de Synthetic Biologics Inc

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio... Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria. Show more

Secteur
Pharmaceutical Preparations
Industrie
Business Services
Siège social
Rockville, Maryland, USA
Fondé
1993

SYN Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SYN - Frequently Asked Questions (FAQ)

What is the current Synthetic Biologics share price?
The current share price of Synthetic Biologics is US$ 1,02
How many Synthetic Biologics shares are in issue?
Synthetic Biologics has 17 043 000 shares in issue
What is the market cap of Synthetic Biologics?
The market capitalisation of Synthetic Biologics is USD 17,38M
What is the 1 year trading range for Synthetic Biologics share price?
Synthetic Biologics has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Synthetic Biologics?
The price to earnings ratio of Synthetic Biologics is -1,58
What is the reporting currency for Synthetic Biologics?
Synthetic Biologics reports financial results in USD
What is the latest annual profit for Synthetic Biologics?
The latest annual profit of Synthetic Biologics is USD -18,35M
What is the registered address of Synthetic Biologics?
The registered address for Synthetic Biologics is 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MARYLAND, 20850
What is the Synthetic Biologics website address?
The website address for Synthetic Biologics is www.syntheticbiologics.com
Which industry sector does Synthetic Biologics operate in?
Synthetic Biologics operates in the BUSINESS SERVICES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26,1194
(0,00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30,06
(0,00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26,7055
(0,00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 28,53
(0,00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25,1328
(0,00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26,1194
(0,00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30,06
(0,00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26,7055
(0,00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 28,53
(0,00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25,1328
(0,00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26,1194
(0,00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30,06
(0,00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26,7055
(0,00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 28,53
(0,00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25,1328
(0,00%)
0
Aucune Discussion Trouvée
Ajouter une Discussion